肺结核治疗的新方向——抗结核药物的肺部递送(6)
[45] Eedara BB， Tucker IG， Das SC. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis[J]. Int J Pharm， 2016， 506(1-2)：174-183.
[46] Parumasivam T， Chan JG， Pang A， et al. In vitro evaluation of novel inhalable dry powders consisting of thioridazine and rifapentine for rapid tuberculosis treatment[J]. Eur J Pharm Biopharm， 2016， 107： 205-214.
[47] Goyal AK， Garg T， Rath G， et al. Development and characterization of nanoembedded microparticles for pulmonary delivery of antitubercular drugs against experimental tuberculosis[J]. Mol Pharm， 2015， 12(11)： 3839-3850.
[48] Garg T， Goyal AK， Rath G， et al. Spray-dried particles as pulmonary delivery system of anti-tubercular drugs： design， optimization， in vitro and in vivo evaluation[J/OL]. Pharm Dev Technol， 2015， 1-10. DOI： 10.3109/10837450.2015.1081613.
[49] Parumasivam T， Leung SS， Quan DH， et al. Rifapentineloaded PLGA microparticles for tuberculosis inhaled therapy： Preparation and in vitro aerosol characterization[J]. Eur J Pharm Sci， 2016， 88： 1-11., 百拇医药(谌茜)
[46] Parumasivam T， Chan JG， Pang A， et al. In vitro evaluation of novel inhalable dry powders consisting of thioridazine and rifapentine for rapid tuberculosis treatment[J]. Eur J Pharm Biopharm， 2016， 107： 205-214.
[47] Goyal AK， Garg T， Rath G， et al. Development and characterization of nanoembedded microparticles for pulmonary delivery of antitubercular drugs against experimental tuberculosis[J]. Mol Pharm， 2015， 12(11)： 3839-3850.
[48] Garg T， Goyal AK， Rath G， et al. Spray-dried particles as pulmonary delivery system of anti-tubercular drugs： design， optimization， in vitro and in vivo evaluation[J/OL]. Pharm Dev Technol， 2015， 1-10. DOI： 10.3109/10837450.2015.1081613.
[49] Parumasivam T， Leung SS， Quan DH， et al. Rifapentineloaded PLGA microparticles for tuberculosis inhaled therapy： Preparation and in vitro aerosol characterization[J]. Eur J Pharm Sci， 2016， 88： 1-11., 百拇医药(谌茜)